500k Covid consumer selftests from Acon Flowflex The Acon Biotech Flowflex SARS-CoV-2 antigen test is a self-test for the detection of the COVID-19 antigen in human nasal swabs. The nasal swab only needs to be inserted 2.5 cm deep into the nasal cavity and the test results can be read in 15-30 minutes. This self-test is easy to use for consumers. With the CE0123 status, Acon Flowflex received, these tests are automatically allowed to be sold to consumers throughout Europe.
Quantity: 250,000 (250K) Lyher - 1 tests per package - price ¬ 1.70 officially approved by the BfArM test suitable for lay use rapid sampling through the nose user-friendly step-by-step instructions Test result within 15 minutes LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) from the manufacturer Hangzhou Laihe Biotech Co., Ltd., China If interested, just let us know Quantity: 250.000 (250K) Lyher â?? 1 tests per package â?? Preis â?¬1,70 offiziell durch das BfArM zugelassener Test geeignet f�¼r Laienanwendungen schnelle Probenentnahme durch die Nase benutzerfreundliche Schritt-f�¼r-Schritt-Anleitung Testergebnis innerhalb von 15 Minuten LYHER Novel Coronavirus (COVID-19) Antigen Test Kit (Colloidal Gold) des Herstellers Hangzhou Laihe Biotech Co., Ltd., China
Coronavirus Ag Rapid Test Cassette (Swab) have been placed on the European Market, based on the following performance characteristics (which are also included in the IFU included in each test kit) Coronavirus Ag Rapid Test Cassette (Swab) Method Coronavirus Ag Rapid Test Cassette Total Results Relative Sensitivity: 86.7% Relative Specificity: 100% Accuracy: 96.3% Coronavirus Ag Rapid Test Cassette (Swab) The CE mark has been applied as the products fit the definition of an in vitro diagnostic medical device as defined in the IVD Directive and are classified as a general IVD products as they are not included in List A or List B, and they are not intended to be used by lay users. Please note that this
The NeoPlexTM COVID-19 Detection Kit Assay is a real-time RT-PCR in vitro diagnostic test intended for the qualitative detection of RNA from SARS-CoV-2 isolated and purified from respiratory specimens* obtained from individuals who meet COVID-19 clinical and/or epidemiological criteria. The NeoPlexTM COVID-19 Detection Kit is for use only under Emergency Use Authorization (EUA) in the US laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.�§263a, to perform high complexity tests. CE & FDA Approved and MHRA Registered for UK
